Why Proto Labs Stock Crashed Back 12.6% Today
I won't say, "I told you so." In fact, I didn't tell you so -- not outright at least. But in discussing Proto Labs' (NYSE: PRLB) remarkable 12.3% jump in stock price yesterday, I think I at least implied that there wasn't any good reason for it and that investors were lumping in Proto Labs stock with a much different story.
Specifically, the story of how 3-D printer-maker 3D Systems (NYSE: DDD) is getting into the human body-parts-printing business.
To refresh your memory, yesterday, 3D announced that it is expanding its partnership with United Therapeutics Corporation (NASDAQ: UTHR), whereby 3D uses a "Print to Perfusion" process to 3D print scaffoldings that United Therapeutics then uses to grow human tissue, essentially creating artificial human organs for medical research and surgical transportation.
Source Fool.com
